Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The paradoxical psychological effects of lysergic acid diethylamide (LSD)
Robin Carhart‐Harris, Mendel Kaelen, Mark Bolstridge, et al.
Psychological Medicine (2016) Vol. 46, Iss. 7, pp. 1379-1390
Open Access | Times Cited: 266

Showing 1-25 of 266 citing articles:

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin Carhart‐Harris, Mark Bolstridge, James Rucker, et al.
The Lancet Psychiatry (2016) Vol. 3, Iss. 7, pp. 619-627
Open Access | Times Cited: 1283
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Robin Carhart‐Harris, Karl Friston
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 316-344
Open Access | Times Cited: 770
Serotonin and brain function: a tale of two receptors
RL Carhart-Harris, DJ Nutt
Journal of Psychopharmacology (2017) Vol. 31, Iss. 9, pp. 1091-1120
Open Access | Times Cited: 593
Psychedelics and the essential importance of context
Robin Carhart‐Harris, Leor Roseman, Eline Haijen, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 7, pp. 725-731
Closed Access | Times Cited: 504
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Robin Carhart‐Harris, Guy M. Goodwin
Neuropsychopharmacology (2017) Vol. 42, Iss. 11, pp. 2105-2113
Open Access | Times Cited: 500
Psychedelics and Psychedelic-Assisted Psychotherapy
Collin Reiff, Elon E. Richman, Charles B. Nemeroff, et al.
American Journal of Psychiatry (2020) Vol. 177, Iss. 5, pp. 391-410
Closed Access | Times Cited: 451
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression
Rosalind Watts, Camilla Day, Jacob Krzanowski, et al.
Journal of Humanistic Psychology (2017) Vol. 57, Iss. 5, pp. 520-564
Closed Access | Times Cited: 444
Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin
Michael Schartner, Robin Carhart‐Harris, Adam B. Barrett, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 362
Predicting Responses to Psychedelics: A Prospective Study
Eline Haijen, Mendel Kaelen, Leor Roseman, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 317
Psychedelics, Meditation, and Self-Consciousness
Raphaël Millière, Robin Carhart‐Harris, Leor Roseman, et al.
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 305
LSD‐induced entropic brain activity predicts subsequent personality change
Alexander V. Lebedev, Mendel Kaelen, Martin Lövdén, et al.
Human Brain Mapping (2016) Vol. 37, Iss. 9, pp. 3203-3213
Open Access | Times Cited: 287
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
Frederick S. Barrett, Matthew P. Bradstreet, Jeannie‐Marie Leoutsakos, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 12, pp. 1279-1295
Open Access | Times Cited: 263
Effective connectivity changes in LSD-induced altered states of consciousness in humans
Katrin H. Preller, Adeel Razi, Peter Zeidman, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 7, pp. 2743-2748
Open Access | Times Cited: 257
Effects of psilocybin therapy on personality structure
David Erritzøe, Leor Roseman, Matthew M. Nour, et al.
Acta Psychiatrica Scandinavica (2018) Vol. 138, Iss. 5, pp. 368-378
Open Access | Times Cited: 223
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Patrick C. Dolder, Yasmin Schmid, Felix Müller, et al.
Neuropsychopharmacology (2016) Vol. 41, Iss. 11, pp. 2638-2646
Open Access | Times Cited: 211
Psychedelics, Personality and Political Perspectives
Matthew M. Nour, Lisa Evans, Robin Carhart‐Harris
Journal of Psychoactive Drugs (2017) Vol. 49, Iss. 3, pp. 182-191
Open Access | Times Cited: 205
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
Natasha L. Mason, Kim P. C. Kuypers, Felix Müller, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 2003-2011
Open Access | Times Cited: 202
Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD
Gustavo Deco, Josephine Cruzat, Joana Cabral, et al.
Current Biology (2018) Vol. 28, Iss. 19, pp. 3065-3074.e6
Open Access | Times Cited: 200
Modern Clinical Research on LSD
Matthias E. Liechti
Neuropsychopharmacology (2017) Vol. 42, Iss. 11, pp. 2114-2127
Open Access | Times Cited: 197
Long-lasting subjective effects of LSD in normal subjects
Yasmin Schmid, Matthias E. Liechti
Psychopharmacology (2017) Vol. 235, Iss. 2, pp. 535-545
Open Access | Times Cited: 196
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Friederike Holze, Patrick Vizeli, Felix Müller, et al.
Neuropsychopharmacology (2019) Vol. 45, Iss. 3, pp. 462-471
Open Access | Times Cited: 187
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
Rafael G. dos Santos, José Carlos Bouso, Miguel Ángel Alcázar‐Córcoles, et al.
Expert Review of Clinical Pharmacology (2018) Vol. 11, Iss. 9, pp. 889-902
Closed Access | Times Cited: 186
Alterations of consciousness and mystical-type experiences after acute LSD in humans
Matthias E. Liechti, Patrick C. Dolder, Yasmin Schmid
Psychopharmacology (2016) Vol. 234, Iss. 9-10, pp. 1499-1510
Open Access | Times Cited: 184
Long-term effects of psychedelic drugs: A systematic review
Jacob S. Aday, Cayla M. Mitzkovitz, Emily K. Bloesch, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 113, pp. 179-189
Closed Access | Times Cited: 183
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Friederike Holze, Patrick Vizeli, Laura Ley, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 3, pp. 537-544
Open Access | Times Cited: 178
Page 1 - Next Page

Scroll to top